Literature DB >> 239076

The behavior of carbenicillin as a nonreabsorbable anion.

H I Lipner, F Ruzany, M Dasgupta, P D Lief, N Bank.   

Abstract

In order to study the mechanism of hypokalemic alkalosis which occurs in some patients being treated with disodium carbenicillin, renal clearance experiments were carried out in rats and observations were made on electrical changes in isolated toad bladders. In rats maintained on a sodium-free diet, intravenous infusion of carbenicillin at 40 mg. per hour resuited in an immediate diuresis characterized by a striking increase in K and NH4 excretion, and progressive acidification of the urine. In a control group of rats, also prepared with a sodium free diet, intravenous infusion of mannitol resulted in a comparable diuresis, but no significant changes in K and NH4 excretion, and no acidification of the urine. The urinary changes in the carbenicillin-treated rats could not be accounted for by any alterations in blood electrolytes, acid-base values, or glomerular filtration rate (GFR). Isonatric, isohydric substitution of carbenicillin for chloride in the mucosal bathing media of toad bladders mounted in Ussing chambers resulted in a reversible increase in electrical potential (PD) and resistance (R) without a comparable change in short-circuit current (SCC). Substitution in the serosal medium resulted in a reversal of polarity of PD and SCC in 4 of 9 experiments, a finding best explained by more rapid movement of chloride from M leads to S than carbenicillin movement from S leads to M (a chloride diffusion potential). The observations in both the rat and toad bladder experiments are consistent with the view that carbenicillin behaves as a nonreabsorbable anion. Hypokalemic alkalosis in patients receiving this drug can thus be attributed to increased electrical negativity of the distal nephron with subsequent enhancement of K and H secretion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239076

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Drug-induced endocrine and metabolic disorders.

Authors:  Chaker Ben Salem; Raoudha Slim; Bouraoui Elouni; Houssem Hmouda; Kamel Bouraoui
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  The Stewart approach--one clinician's perspective.

Authors:  T John Morgan
Journal:  Clin Biochem Rev       Date:  2009-05

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

Review 4.  Drug prescribing in renal failure.

Authors:  W M Bennett
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

Review 5.  Drug-induced electrolyte abnormalities.

Authors:  E P Brass; W L Thompson
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

6.  Hypokalaemia in leukaemia.

Authors:  A A Nanji; J Denegri
Journal:  Postgrad Med J       Date:  1981-08       Impact factor: 2.401

7.  Toxic and adverse reactions encountered with new beta-lactam antibiotics.

Authors:  M F Parry
Journal:  Bull N Y Acad Med       Date:  1984-05

Review 8.  Drug-induced acid-base disorders.

Authors:  Daniel Kitterer; Matthias Schwab; M Dominik Alscher; Niko Braun; Joerg Latus
Journal:  Pediatr Nephrol       Date:  2014-11-05       Impact factor: 3.714

Review 9.  Fluid, electrolyte and acid-base disorders associated with antibiotic therapy.

Authors:  R Zietse; R Zoutendijk; E J Hoorn
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

10.  Spurious rise in total carbon dioxide and chloride with negative anion gap after cystogram.

Authors:  L O Abdel-Wareth; D S Lirenman; A C Halstead; D McLellan; B C Carleton
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.